Cells must continuously adapt to changes in their internal and external environment.

Temperature fluctuations, oxidative damage, nutrient deprivation, hypoxia, toxins, infection, mechanical stress, DNA damage, and accumulation of misfolded proteins can disrupt normal cellular functions.

To counteract these challenges, cells activate sophisticated stress-response mechanisms.

The primary purpose of cellular stress responses is to restore homeostasis and protect cells from injury. These responses may involve changes in gene expression, metabolism, protein folding, organelle function, antioxidant capacity, and cellular degradation pathways.

However, cellular stress responses are not always protective.

When stress is mild or transient, adaptive responses can restore cellular function. In contrast, prolonged or severe stress can activate cell-death pathways and inflammatory responses.

This distinction is important for understanding disease development.

Cancer cells, for example, can exploit stress-response pathways to survive hypoxia, nutrient deprivation, and genomic instability. Conversely, excessive stress in neurons can contribute to neurodegeneration.

Similarly, persistent endoplasmic reticulum stress can contribute to metabolic disease, while oxidative stress can promote cardiovascular and inflammatory disorders.

This review examines the major cellular stress-response mechanisms and discusses their roles in human disease pathogenesis.

Cellular Homeostasis and Stress Detection

Cellular homeostasis requires precise regulation of protein synthesis, energy production, redox balance, ion concentrations, and organelle function.

Cells possess molecular sensors that detect deviations from normal physiological conditions.

These sensors activate signaling cascades that modify transcription, translation, metabolism, and cellular survival.

Important cellular stress sensors include:

• PERK;
• IRE1;
• ATF6;
• AMPK;
• mTOR;
• HIF proteins;
• Nrf2;
• p53; and
• Heat shock factors.

Activation of these sensors initiates adaptive responses that depend on the type, intensity, and duration of stress.

Major Cellular Stress Responses

Several interconnected stress-response pathways contribute to cellular adaptation.

These pathways communicate extensively and collectively determine cellular fate.

Heat Shock Response

The heat shock response is activated when cells experience conditions that disrupt protein structure.

Although originally identified in response to elevated temperature, the response can also be triggered by oxidative stress, toxins, inflammation, hypoxia, and metabolic disturbances.

Heat shock factor 1 is a major transcriptional regulator of the response.

Following activation, HSF1 stimulates expression of heat shock proteins.

Heat shock proteins function as molecular chaperones that assist protein folding and prevent inappropriate protein aggregation.

Important heat shock proteins include HSP70 and HSP90.

The heat shock response is therefore essential for maintaining protein homeostasis.

Heat Shock Proteins and Disease

Heat shock proteins have complex roles in disease.

In neurodegenerative disorders, insufficient chaperone activity may contribute to accumulation of misfolded proteins.

In cancer, however, increased heat shock protein expression can support tumor-cell survival.

Cancer cells experience substantial proteotoxic and metabolic stress and may depend on molecular chaperones to maintain protein stability.

Consequently, heat shock proteins have been investigated as potential therapeutic targets in oncology.

Oxidative Stress Response

Oxidative stress occurs when production of reactive oxygen species exceeds the capacity of antioxidant systems.

Reactive oxygen species include:

• Superoxide;
• Hydrogen peroxide;
• Hydroxyl radicals; and
• Other reactive oxidant molecules.

ROS are generated during normal mitochondrial respiration and several enzymatic reactions.

At controlled levels, ROS participate in signaling.

Excessive ROS, however, can damage proteins, lipids, DNA, and cellular membranes.

Cells respond by activating antioxidant defense systems.

Nrf2-Mediated Antioxidant Response

Nuclear factor erythroid 2-related factor 2 is a central regulator of cellular antioxidant defense.

Under basal conditions, Nrf2 is regulated by its cytoplasmic inhibitor.

During oxidative or electrophilic stress, Nrf2 becomes stabilized and translocates to the nucleus.

It then activates expression of antioxidant and detoxification genes.

These genes include enzymes involved in glutathione metabolism, NADPH production, and detoxification of reactive molecules.

The Nrf2 pathway therefore provides an important protective mechanism against oxidative damage.

Oxidative Stress and Disease

Persistent oxidative stress contributes to numerous pathological conditions.

Oxidative stress frequently interacts with inflammatory pathways, creating feedback mechanisms that sustain tissue injury.

Endoplasmic Reticulum Stress

The endoplasmic reticulum is responsible for synthesis, folding, and processing of many cellular proteins.

When protein-folding capacity is exceeded, unfolded or misfolded proteins accumulate.

This condition is known as endoplasmic reticulum stress.

Cells respond through the unfolded protein response.

The primary sensors of the unfolded protein response are:

• PERK;
• IRE1; and
• ATF6.

These pathways initially reduce protein-folding pressure and increase cellular capacity to restore protein homeostasis.

PERK Signaling

PERK is activated following accumulation of unfolded proteins.

It phosphorylates eukaryotic initiation factor 2 alpha, reducing general protein translation.

This decreases the number of newly synthesized proteins entering the endoplasmic reticulum.

At the same time, selective stress-response proteins can continue to be produced.

Persistent PERK signaling may contribute to apoptosis when ER stress cannot be resolved.

IRE1 Signaling

IRE1 is an endoplasmic reticulum transmembrane protein with kinase and endoribonuclease activities.

Following activation, IRE1 promotes processing of XBP1 messenger RNA.

The resulting transcription factor increases expression of proteins involved in protein folding, secretion, and ER quality control.

IRE1 can also influence inflammatory and cell-death pathways.

ATF6 Signaling

ATF6 is another ER stress sensor.

Following ER stress, ATF6 undergoes transport and proteolytic activation.

The activated transcription factor enters the nucleus and stimulates expression of genes involved in protein folding and ER-associated degradation.

Together, PERK, IRE1, and ATF6 coordinate the unfolded protein response.

ER Stress and Metabolic Disease

Persistent ER stress has been associated with metabolic disorders.

High nutrient availability and lipid accumulation can increase protein-folding and metabolic stress.

ER stress may interfere with insulin signaling and contribute to insulin resistance.

Pancreatic β-cells are also sensitive to ER stress because of their high secretory activity.

Persistent ER dysfunction can therefore contribute to β-cell impairment and diabetes progression.

ER Stress and Neurodegeneration

Neurons depend heavily on protein quality-control systems.

Accumulation of misfolded proteins can activate ER stress pathways.

If adaptive mechanisms fail, prolonged ER stress can activate apoptotic signaling.

This process has been investigated in several neurodegenerative disorders characterized by abnormal protein aggregation.

DNA Damage Response

DNA is continuously exposed to endogenous and environmental damage.

Sources include:

• Reactive oxygen species;
• Ultraviolet radiation;
• Ionizing radiation;
• Chemical agents;
• Replication errors; and
• Metabolic stress.

Cells possess extensive DNA damage-response mechanisms to detect and repair damaged DNA.

Important regulators include ATM, ATR, checkpoint proteins, DNA repair enzymes, and p53.

p53-Mediated Stress Response

p53 is a major regulator of cellular responses to DNA damage.

Following activation, p53 can induce cell-cycle arrest, allowing time for DNA repair.

If damage is too severe, p53 can activate apoptosis or other forms of cellular senescence.

This function helps prevent accumulation of genetically abnormal cells.

Loss of p53 function can therefore increase genomic instability and cancer risk.

DNA Damage and Cancer

DNA damage is a major driver of carcinogenesis.

If damaged DNA is repaired accurately, cellular integrity can be preserved.

However, defective DNA repair can allow mutations to accumulate.

Cancer cells frequently develop mechanisms that disable stress checkpoints.

This allows them to survive despite genomic instability.

Consequently, DNA damage-response pathways represent important therapeutic targets in oncology.

Hypoxia Response

Hypoxia occurs when oxygen availability is insufficient to meet cellular requirements.

Cells respond through hypoxia-inducible factors.

HIF-1α is particularly important in regulating adaptation to low oxygen.

Under normal oxygen conditions, HIF-1α is continuously degraded.

During hypoxia, its degradation is inhibited, allowing it to accumulate and regulate gene expression.

HIF-Mediated Metabolic Adaptation

HIF signaling promotes adaptation to low oxygen by increasing expression of genes involved in:

• Glucose uptake;
• Glycolysis;
• Angiogenesis;
• Erythropoiesis;
• Cell survival; and
• Oxygen delivery.

These responses help cells maintain energy production under oxygen-limited conditions.

However, chronic hypoxia can also promote pathological changes.

Hypoxia and Cancer

Solid tumors frequently contain regions of low oxygen.

Tumor cells can use HIF signaling to adapt to hypoxia.

HIF-dependent pathways promote angiogenesis, metabolic adaptation, invasion, and survival.

Therefore, hypoxia responses can contribute to tumor progression.

Mitochondrial Stress Response

Mitochondria are major sources of cellular energy.

They also regulate calcium homeostasis, ROS production, apoptosis, and metabolic signaling.

Mitochondrial dysfunction can result from oxidative stress, toxins, genetic abnormalities, aging, or metabolic disturbances.

Cells respond by activating mitochondrial quality-control mechanisms.

These include:

• Mitophagy;
• Mitochondrial unfolded protein response;
• Antioxidant defense;
• Mitochondrial biogenesis; and
• Regulation of mitochondrial dynamics.

Mitophagy and Cellular Protection

Mitophagy is a selective form of autophagy that removes damaged mitochondria.

Defective mitochondria can generate excessive ROS and release signals capable of activating inflammatory pathways.

By removing damaged mitochondria, mitophagy helps maintain mitochondrial quality.

Impaired mitophagy has been associated with metabolic and neurodegenerative diseases.

Energy Stress and AMPK

Cells require continuous energy production to maintain physiological functions.

When ATP availability decreases, AMP and ADP levels increase.

AMP-activated protein kinase responds to this energy imbalance.

AMPK promotes energy-producing pathways while reducing energy-consuming processes.

It also stimulates autophagy and influences mitochondrial metabolism.

The AMPK pathway therefore connects energy status with cellular stress adaptation.

mTOR and Cellular Stress

The mammalian target of rapamycin pathway is a major regulator of growth, protein synthesis, and metabolism.

When nutrients and growth factors are abundant, mTOR promotes anabolic processes.

During nutrient deprivation, mTOR activity decreases.

This permits activation of autophagy and other cellular conservation mechanisms.

Abnormal mTOR signaling has been implicated in cancer, metabolic disorders, and aging.

Autophagy as a Stress-Adaptation Mechanism

Autophagy allows cells to degrade damaged proteins and organelles.

It becomes particularly important during nutrient deprivation and organelle stress.

Autophagy can provide metabolic substrates and remove potentially toxic cellular components.

However, prolonged or dysregulated autophagy can contribute to pathological processes.

The biological effect depends on the cellular context and the level of autophagic activity.

Inflammatory Stress Responses

Inflammation is closely connected to cellular stress.

Damaged cells can release danger-associated molecular patterns.

These signals activate immune receptors and inflammatory pathways.

NF-κB is a central transcriptional regulator of inflammation.

Oxidative stress, ER stress, mitochondrial dysfunction, and DNA damage can all influence inflammatory signaling.

Persistent activation may lead to chronic tissue inflammation and injury.

Cellular Stress and Apoptosis

When adaptive mechanisms fail, cells may activate programmed cell-death pathways.

Mitochondrial dysfunction can lead to release of cytochrome c and activation of caspases.

ER stress can activate apoptotic pathways through multiple mechanisms.

DNA damage can activate p53-dependent apoptosis.

Thus, apoptosis represents an important endpoint of severe cellular stress.

Cellular Senescence

Cellular senescence is a stable state of growth arrest that can occur following persistent cellular stress.

Senescence can be induced by:

• DNA damage;
• Oxidative stress;
• Telomere shortening;
• Oncogene activation; and
• Mitochondrial dysfunction.

Senescent cells remain metabolically active and can release inflammatory molecules.

Accumulation of senescent cells has been associated with aging and chronic disease.

Cellular Stress Responses in Aging

Aging is associated with progressive changes in cellular stress resistance.

Several protective mechanisms become less efficient with age.

These include:

• Protein quality control;
• Antioxidant defense;
• DNA repair;
• Autophagy;
• Mitochondrial quality control; and
• Cellular senescence regulation.

Accumulation of damaged cellular components may therefore contribute to age-associated disease.

Cellular Stress Responses in Cancer

Cancer cells experience multiple forms of stress simultaneously.

Rapid proliferation increases metabolic demand.

Tumor environments can contain hypoxia, nutrient limitation, oxidative stress, and protein-folding stress.

Cancer cells activate stress-response pathways to survive these conditions.

Because tumor cells can become dependent on these pathways, stress-response mechanisms are potential therapeutic targets.

Cellular Stress Responses in Neurodegenerative Disease

Neurons are especially susceptible to cellular stress because of their high metabolic activity and limited regenerative capacity.

Mitochondrial dysfunction, oxidative stress, protein misfolding, and impaired autophagy can interact to promote neuronal damage.

Persistent activation of stress pathways may eventually lead to synaptic dysfunction and neuronal death.

These mechanisms are relevant to several neurodegenerative conditions.

Cellular Stress in Cardiovascular Disease

Cardiac tissues require continuous energy production.

Mitochondrial dysfunction and oxidative stress can therefore have significant consequences for cardiac cells.

Ischemia causes oxygen and nutrient deprivation, triggering hypoxia and energy stress responses.

If stress becomes severe, apoptosis and other forms of cell death can contribute to myocardial injury.

Endothelial oxidative stress can also promote vascular dysfunction.

Cellular Stress in Liver Disease

The liver is exposed to metabolic stress, toxins, inflammatory mediators, and changes in lipid availability.

Excessive lipid accumulation can increase oxidative and ER stress.

Persistent stress may activate inflammatory signaling, hepatocyte death, and fibrotic responses.

The interaction of these pathways contributes to progression of chronic liver disease.

Cellular Stress in Kidney Disease

Renal cells are exposed to metabolic and oxidative challenges.

Mitochondrial dysfunction and oxidative stress can contribute to tubular injury.

ER stress and inflammatory signaling may further amplify cellular damage.

Persistent injury can promote fibrosis and progressive loss of renal function.

Review Design

The present article was prepared as a narrative review examining cellular stress-response pathways and their involvement in human disease pathogenesis.

Literature Search

Scientific publications were evaluated through biomedical databases and peer-reviewed scientific journals.

Search terms included combinations of:

“cellular stress,” “stress response,” “oxidative stress,” “endoplasmic reticulum stress,” “heat shock response,” “DNA damage response,” “hypoxia,” “mitochondrial stress,” “autophagy,” “AMPK,” “mTOR,” “Nrf2,” “p53,” “cancer,” “neurodegeneration,” “metabolic disease,” “cardiovascular disease,” and “cellular senescence.”

Inclusion Criteria

Studies were considered relevant when they investigated:

• Cellular stress-response mechanisms;
• Molecular stress sensors;
• Stress-related signaling pathways;
• Cellular adaptation and survival;
• Stress-induced cell death;
• Stress responses in human disease; or
• Therapeutic targeting of stress pathways.

Exclusion Criteria

Studies without substantial relevance to cellular stress mechanisms or disease pathogenesis were excluded from the primary synthesis.

Data Synthesis

Evidence was organized according to major stress-response pathways and their involvement in cancer, metabolic disease, cardiovascular disease, neurodegeneration, liver disease, kidney disease, aging, and inflammation.

Results

The reviewed evidence demonstrates that cellular stress responses are highly interconnected systems that regulate adaptation, survival, and cell death.

The major observations are summarized below.

Overall, the evidence indicates that failure to resolve cellular stress is an important contributor to disease development.

Therapeutic Perspectives

Cellular stress pathways represent attractive therapeutic targets because they influence multiple disease mechanisms.

Nrf2 Modulation

Enhancement of Nrf2-dependent antioxidant responses may protect cells from oxidative damage in selected diseases.

However, excessive Nrf2 activity can potentially benefit cancer cells by increasing their resistance to oxidative stress.

Therapeutic modulation therefore requires careful disease-specific consideration.

HSP Inhibition

Because cancer cells can depend on molecular chaperones, inhibition of selected heat shock proteins has been investigated as an anticancer strategy.

UPR Modulation

Targeting PERK, IRE1, or ATF6 may help reduce pathological ER stress.

Such approaches require careful balancing because the unfolded protein response also performs essential protective functions.

AMPK Activation

AMPK activation can improve metabolic adaptation and promote cellular quality-control mechanisms.

Its therapeutic relevance is being investigated in metabolic and cardiovascular diseases.

mTOR Inhibition

mTOR inhibitors can enhance autophagy and alter cellular metabolism.

These approaches have been explored in cancer, aging, and metabolic disorders.

Targeting Hypoxia Signaling

In cancer, targeting HIF-dependent signaling may interfere with tumor adaptation to low oxygen.

DNA Damage Response

DNA repair pathways are important therapeutic targets in cancer.

Tumors with specific DNA repair defects may be particularly sensitive to inhibitors of complementary repair pathways.

Cellular stress responses are fundamental mechanisms that allow cells to survive changing environmental conditions.

Rather than representing isolated pathways, stress responses form a highly interconnected network.

For example, oxidative stress can damage mitochondria, resulting in increased ROS production.

Damaged mitochondria can activate mitophagy, inflammatory signaling, and apoptosis.

At the same time, oxidative stress can activate Nrf2, which increases antioxidant defenses.

This illustrates how stress pathways can both amplify and suppress cellular injury.

The unfolded protein response provides another example of this balance.

During moderate ER stress, PERK, IRE1, and ATF6 reduce protein-folding pressure and increase the cell's capacity to restore protein homeostasis.

If ER stress persists, however, these same pathways can contribute to inflammation and apoptosis.

Therefore, the duration and intensity of stress are critical determinants of cellular outcome.

Hypoxia signaling is similarly context-dependent.

In normal physiology, HIF activation enables cells to adapt to low oxygen.

In cancer, however, tumors can exploit HIF signaling to promote angiogenesis and metabolic adaptation.

Stress responses can therefore have either protective or pathological consequences depending on the biological context.

Cancer represents a particularly important example because malignant cells are exposed to multiple simultaneous stressors.

Rapid proliferation increases metabolic and proteotoxic stress, while inadequate vascularization produces hypoxia and nutrient deprivation.

Cancer cells frequently activate antioxidant, heat shock, autophagy, and DNA repair mechanisms to survive these conditions.

This dependence creates potential therapeutic vulnerabilities.

Neurodegenerative diseases provide a contrasting situation.

In these disorders, the inability to resolve protein misfolding, oxidative damage, and mitochondrial dysfunction can lead to progressive neuronal injury.

Enhancing cellular quality-control mechanisms may therefore provide therapeutic benefit.

A major challenge is that stress-response pathways are also necessary for normal cellular function.

Complete suppression of a stress pathway may therefore produce harmful effects.

Future therapeutic approaches should aim for selective modulation rather than complete pathway inhibition.

Another important issue is disease stage.

A pathway that is protective during early disease may become harmful during chronic disease.

Understanding the temporal dynamics of cellular stress responses will therefore be essential for effective therapeutic development.

Future Perspectives

Future studies should investigate cellular stress responses at single-cell and tissue-specific levels.

Modern transcriptomic, proteomic, metabolomic, and imaging technologies can provide detailed information about how individual cells respond to stress.

Integration of these datasets may identify molecular signatures that distinguish adaptive stress from irreversible cellular injury.

Another important research direction is development of biomarkers for cellular stress.

Circulating markers of oxidative stress, ER stress, mitochondrial dysfunction, and inflammation could potentially assist in disease diagnosis and monitoring.

Precision medicine approaches may also allow stress-response pathways to be targeted according to individual molecular profiles.

In cancer, for example, tumors with specific stress-response dependencies may be particularly sensitive to targeted pathway inhibition.

In neurodegenerative and metabolic diseases, enhancement of protective stress responses may provide a different therapeutic strategy.

Development of tissue-specific delivery systems may further improve safety and efficacy

Cellular stress responses represent an essential molecular defense system that maintains cellular integrity under adverse conditions.

Major stress pathways include the heat shock response, oxidative stress response, unfolded protein response, DNA damage response, hypoxia signaling, mitochondrial quality control, AMPK signaling, mTOR regulation, and autophagy.

These mechanisms initially promote cellular adaptation and survival by restoring protein homeostasis, maintaining redox balance, repairing DNA, conserving energy, and removing damaged cellular components.

However, persistent or excessive stress can overwhelm these protective mechanisms and activate apoptosis, inflammation, senescence, fibrosis, and tissue dysfunction.

Dysregulated cellular stress responses contribute to cancer, neurodegenerative disorders, cardiovascular diseases, metabolic disorders, liver disease, kidney disease, and age-related conditions.

The therapeutic importance of these pathways lies in their ability to influence both disease progression and cellular resistance to treatment.

Future research should focus on selective, tissue-specific, and context-dependent modulation of stress pathways.

A deeper understanding of cellular stress biology may provide new biomarkers and therapeutic opportunities for preventing and treating complex human diseases.

1. Fulda S, Gorman AM, Hori O, Samali A. Cellular stress responses: cell survival and cell death. International Journal of Cell Biology. 2010;2010:214074.
2. Pakos-Zebrucka K, Koryga I, Mnich K, Ljujic M, Samali A, Gorman AM. The integrated stress response. EMBO Reports. 2016;17:1374–1395.
3. Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011;334:1081–1086.
4. Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nature Reviews Molecular Cell Biology. 2012;13:89–102.
5. Kroemer G, Mariño G, Levine B. Autophagy and the integrated stress response. Molecular Cell. 2010;40:280–293.
6. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010;140:900–917.
7. Ma Q. Role of Nrf2 in oxidative stress and toxicity. Annual Review of Pharmacology and Toxicology. 2013;53:401–426.
8. Hayes JD, Dinkova-Kostova AT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends in Biochemical Sciences. 2014;39:199–218.
9. Morimoto RI. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes & Development. 2008;22:1427–1438.
10. Calderwood SK, Murshid A, Prince T. The shock of aging: molecular chaperones and the heat shock response in longevity and aging. Gerontology. 2009;55:550–558.
11. Semenza GL. Oxygen sensing, homeostasis, and disease. New England Journal of Medicine. 2019;381:234–243.
12. Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Molecular Cell. 2008;30:393–402.
13. Shiloh Y, Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nature Reviews Molecular Cell Biology. 2013;14:197–210.
14. Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell. 2009;137:413–431.
15. Hardie DG. AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels. Annual Review of Nutrition. 2014;34:31–55.
16. Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168:960–976.
17. Kim J, Guan KL. mTOR as a central hub of nutrient signalling and cell growth. Nature Cell Biology. 2019;21:63–71.
18. Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G. Mitochondrial control of cellular life, stress, and death. Circulation Research. 2012;111:1198–1207.
19. Youle RJ, Narendra DP. Mechanisms of mitophagy. Nature Reviews Molecular Cell Biology. 2011;12:9–14.
20. Green DR, Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature. 2009;458:1127–1130.
21. Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 2006;25:4798–4811.
22. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153:1194–1217.
23. Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nature Reviews Endocrinology. 2018;14:576–590.
24. Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discovery. 2022;12:31–46.
25. Fulda S. Targeting apoptosis for anticancer therapy. Seminars in Cancer Biology. 2013;23:1–6.